Clinical operations in oncology trials Europe
At the Clinical Operations in Oncology Trials Europe event, taking place on the 22nd-23rd of November in Zurich, we are pleased to bring together the definitive group of executives responsible for clinical operations in oncology and enhancing the partnership with vendors. There will be expert guidance through a first class conference program and numerous networking opportunities.
Session Information:
Title: Strategies for successful oncology recurrence trials
Date: Wednesday, November 23rd, 2022
Time: 12:15 p.m. CET
This presentation will address successful strategies for oncology recurrence trials including a review of operational and read recommendations to help you improve efficiency and quality for your recurrence studies. The speaker will discuss:
- Imaging in the context of surveillance;
- Other procedures for detection of recurrence not discussed;
- Clinical trials design, including disease-free status;
- Central imaging evaluation including: establishing disease free status, detection of recurrence and characterization of recurrence; and
- Operational considerations
Speakers
Paul van Meurs, MD
Director, Medical & Scientific Affairs Oncology at Clario
Paul van Meurs, MD, is currently the Director of Medical & Scientific Affairs, Oncology and is responsible for the oversight of Clario’s medical imaging and specialty solutions. Dr. Muers is a qualified MD with more than 20 years of experience in clinical development within the pharmaceutical industry. He has previous experience at BiOrion as their Chief Business Officer as well as Keosys Medical Imaging and Julius Clinical where he was responsible for business development activities. He is also the editor of the Dutch Textbook of Pharmaceutical Medicine (Published 2014).